ES525361A0 - Procedimiento para preparar un medicamento seguro contra hepatitis que contiene la proteina llamada inactivador cl. - Google Patents
Procedimiento para preparar un medicamento seguro contra hepatitis que contiene la proteina llamada inactivador cl.Info
- Publication number
- ES525361A0 ES525361A0 ES525361A ES525361A ES525361A0 ES 525361 A0 ES525361 A0 ES 525361A0 ES 525361 A ES525361 A ES 525361A ES 525361 A ES525361 A ES 525361A ES 525361 A0 ES525361 A0 ES 525361A0
- Authority
- ES
- Spain
- Prior art keywords
- inactivator
- prepare
- procedure
- containing protein
- protein called
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0023—Heat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/005—Enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/04—Heat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8121—Serpins
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/0008—Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
- C08K5/005—Stabilisers against oxidation, heat, light, ozone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Polymers & Plastics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19823228502 DE3228502A1 (de) | 1982-07-30 | 1982-07-30 | Verfahren zur herstellung des c1-inaktivators und seine verwendung |
Publications (2)
Publication Number | Publication Date |
---|---|
ES525361A0 true ES525361A0 (es) | 1984-11-16 |
ES8501413A1 ES8501413A1 (es) | 1984-11-16 |
Family
ID=6169724
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES524511A Expired ES8404372A1 (es) | 1982-07-30 | 1983-07-28 | Procedimiento para preparar un inactivador, eventualmente exento de virus de hepatitis y eventualmente liofilizable, de la c1-esterasa del sistema de complemento |
ES525361A Expired ES8501413A1 (es) | 1982-07-30 | 1983-09-05 | Procedimiento para preparar un medicamento seguro contra hepatitis que contiene la proteina llamada inactivador cl. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES524511A Expired ES8404372A1 (es) | 1982-07-30 | 1983-07-28 | Procedimiento para preparar un inactivador, eventualmente exento de virus de hepatitis y eventualmente liofilizable, de la c1-esterasa del sistema de complemento |
Country Status (9)
Country | Link |
---|---|
US (1) | US4915945A (es) |
EP (1) | EP0101935B1 (es) |
JP (2) | JPS5944320A (es) |
AT (1) | ATE19590T1 (es) |
AU (1) | AU564614B2 (es) |
CA (1) | CA1223201A (es) |
DE (2) | DE3228502A1 (es) |
ES (2) | ES8404372A1 (es) |
ZA (1) | ZA835561B (es) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT376367B (de) * | 1983-03-16 | 1984-11-12 | Immuno Ag | Verfahren zur herstellung von therapeutisch verabreichbaren, in endbehaeltern abgefuellten plasmaderivaten |
JPH0742235B2 (ja) * | 1985-11-08 | 1995-05-10 | 三共株式会社 | 自己免疫性疾病の予防・治療剤 |
FR2601034B1 (fr) * | 1986-07-03 | 1989-11-17 | Pasteur Institut | Inhibiteur de l'activite de la c1-esterase plasmatique (c1-inhibiteur) et d'autres enzymes proteolytiques du groupe des proteases a serine, son procede de preparation, acides nucleiques codant pour cet inhibiteur, methodes de detection d'affections correlees aux defauts dudit inhibiteur a l'aide d'anticorps ou de sondes nucleotidiques et medicaments contenant ledit inhibiteur de synthese |
FR2618784B1 (fr) * | 1987-07-30 | 1990-04-06 | Lille Transfusion Sanguine | Concentre de proteines coagulables par la thrombine, son procede d'obtention et son utilisation a titre de colle biologique |
JP2729484B2 (ja) * | 1988-04-28 | 1998-03-18 | 株式会社ミドリ十字 | アンチトロンビン−▲iii▼の精製方法 |
US5268363A (en) * | 1989-09-12 | 1993-12-07 | The Beth Israel Hospital Association | Method of treatment to inhibit the undesirable activation of the complement cascade with factor J, an inhibitor of complement C1 |
US5109114A (en) * | 1989-09-12 | 1992-04-28 | Beth Israel Hospital | Characterization and method of isolation for an inhibitor of complement C1 |
US5264549A (en) * | 1989-09-12 | 1993-11-23 | The Beth Israel Hospital Association | Characterization and method of isolation of factor J, an inhibitor of complement C1 |
US5622930A (en) * | 1989-10-27 | 1997-04-22 | Clb | C1 inhibitor muteins and uses thereof |
US5160744A (en) * | 1991-06-27 | 1992-11-03 | Alza Corporation | Verapmil therapy |
DE4222534A1 (de) * | 1992-07-09 | 1994-01-13 | Behringwerke Ag | Verwendung von Komplement-Inhibitoren zur Herstellung eines Arzneimittels zur Prophylaxe und Therapie von entzündlichen Darm- und Hauterkrankungen sowie Purpura |
DE4227762A1 (de) * | 1992-08-24 | 1994-03-03 | Behringwerke Ag | Verwendung eines Kallikrein-Inhibitors zur Herstellung eines Arzneimittels zur Prophylaxe und Therapie bestimmter Krankheiten |
DK0716611T3 (da) * | 1993-09-01 | 2002-05-21 | Sanquin Bloedvoorziening | Fremgangsmåde til at reducere myocardielæsion under akut myocardieinfarkt |
US5547696A (en) * | 1994-10-13 | 1996-08-20 | Novo Nordisk A/S | Pharmaceutical formulation |
JP2000247903A (ja) | 1999-03-01 | 2000-09-12 | Chugai Pharmaceut Co Ltd | 長期安定化製剤 |
WO2001019392A1 (en) | 1999-09-16 | 2001-03-22 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Combination of c1-inh and lung surfactant for the treatment of respiratory disorders |
AT409336B (de) * | 1999-12-22 | 2002-07-25 | Baxter Ag | Verfahren zur herstellung einer c1-esterase-inhibitor (c1-inh)-hältigen zusammensetzung |
JP6190368B2 (ja) | 2011-09-24 | 2017-08-30 | ツェー・エス・エル・ベーリング・ゲー・エム・ベー・ハー | 免疫グロブリンおよびc1−阻害剤を用いる組合せ療法 |
CA2858984C (en) | 2011-12-22 | 2021-01-05 | Csl Behring Gmbh | Use of c1-inhibitor for the treatment of secondary edema of the central nervous system |
KR102403299B1 (ko) | 2013-03-08 | 2022-06-03 | 체에스엘 베링 게엠베하 | 원격 허혈-재관류 손상의 치료 및 예방 |
CA2916399C (en) | 2013-06-28 | 2022-08-02 | Marc Nolte | Combination therapy using a factor xii inhibitor and a c1-inhibitor |
US10532087B2 (en) | 2015-06-03 | 2020-01-14 | Children's Hospital Medical Center | Compositions and methods for treating neonatal biliary atresia |
CN109562149A (zh) | 2016-08-05 | 2019-04-02 | 德国杰特贝林生物制品有限公司 | C1酯酶抑制剂的药物制剂 |
WO2018037046A1 (en) | 2016-08-23 | 2018-03-01 | Csl Behring Gmbh | Method of preventing acute attacks of hereditary angioedema associated with c1 esterase inhibitor deficiency |
US20200069780A1 (en) | 2017-05-16 | 2020-03-05 | Octapharma Ag | C1-esterase inhibitor preparation |
CA3075686A1 (en) | 2017-09-15 | 2019-03-21 | Cedars-Sinai Medical Center | Methods for improving organ function in organ transplant patients |
JP2022505307A (ja) * | 2018-10-17 | 2022-01-14 | ツェー・エス・エル・ベーリング・ゲー・エム・ベー・ハー | C1-inhを精製する方法 |
JP2022538355A (ja) | 2019-07-04 | 2022-09-01 | ツェー・エス・エル・ベーリング・ゲー・エム・ベー・ハー | C1-inhを精製する方法 |
RU2769201C2 (ru) * | 2020-06-23 | 2022-03-29 | Акционерное общество "ГЕНЕРИУМ" | Способ получения высокоочищенного рекомбинантного ингибитора с1-эстеразы человека для медицинского применения |
US20240000908A1 (en) | 2020-11-20 | 2024-01-04 | Csl Behring Gmbh | Method for Treating Antibody-Mediated Rejection |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5322139B2 (es) * | 1973-11-15 | 1978-07-06 | ||
NL7602846A (nl) * | 1976-03-18 | 1977-09-20 | Leuven Res & Dev Vzw | Antiplasmine en een antiserum daartegen. |
JPS5359018A (en) * | 1976-11-10 | 1978-05-27 | Green Cross Corp:The | Concentrated xiii-th blood coagulating factor derived from human placentaand its preparation |
EP0035204B2 (en) * | 1980-03-05 | 1991-05-22 | Miles Inc. | Pasteurized therapeutically active protein compositions |
JPS56154419A (en) * | 1980-04-30 | 1981-11-30 | Green Cross Corp:The | Heat treatment of alpha-fetoprotein-containing aqueous solution |
-
1982
- 1982-07-30 DE DE19823228502 patent/DE3228502A1/de not_active Withdrawn
-
1983
- 1983-07-27 AT AT83107374T patent/ATE19590T1/de not_active IP Right Cessation
- 1983-07-27 EP EP83107374A patent/EP0101935B1/de not_active Expired
- 1983-07-27 DE DE8383107374T patent/DE3363395D1/de not_active Expired
- 1983-07-28 ES ES524511A patent/ES8404372A1/es not_active Expired
- 1983-07-29 ZA ZA835561A patent/ZA835561B/xx unknown
- 1983-07-29 JP JP58137892A patent/JPS5944320A/ja active Granted
- 1983-07-29 AU AU17451/83A patent/AU564614B2/en not_active Ceased
- 1983-07-29 CA CA000433647A patent/CA1223201A/en not_active Expired
- 1983-09-05 ES ES525361A patent/ES8501413A1/es not_active Expired
-
1985
- 1985-04-18 US US06/724,050 patent/US4915945A/en not_active Expired - Lifetime
-
1992
- 1992-07-10 JP JP4183460A patent/JPH07103044B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ES524511A0 (es) | 1984-04-16 |
ATE19590T1 (de) | 1986-05-15 |
EP0101935A1 (de) | 1984-03-07 |
JPH0480886B2 (es) | 1992-12-21 |
DE3228502A1 (de) | 1984-02-02 |
US4915945A (en) | 1990-04-10 |
ES8404372A1 (es) | 1984-04-16 |
CA1223201A (en) | 1987-06-23 |
DE3363395D1 (en) | 1986-06-12 |
JPS5944320A (ja) | 1984-03-12 |
AU564614B2 (en) | 1987-08-20 |
JPH05306236A (ja) | 1993-11-19 |
JPH07103044B2 (ja) | 1995-11-08 |
EP0101935B1 (de) | 1986-05-07 |
ES8501413A1 (es) | 1984-11-16 |
ZA835561B (en) | 1984-03-28 |
AU1745183A (en) | 1984-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES525361A0 (es) | Procedimiento para preparar un medicamento seguro contra hepatitis que contiene la proteina llamada inactivador cl. | |
DE3379644D1 (en) | Adsorbent and process for preparing the same | |
NO154864C (no) | Fremgangsmaate ved fremstilling av renset detoksifisert endotoksin. | |
DE3366494D1 (de) | New 6-substituted-s-triazolo(3,4-a)phthalazine derivatives | |
GB1531558A (en) | Compositions having affinity for hepatitis virus and method for hepatitis virus removal | |
DE3370482D1 (en) | Substituted 8-phenylxanthines | |
FI852522A0 (fi) | Menetelmä tymopentiinianalogien valmistamiseksi | |
DE3363642D1 (en) | Process for the preparation of protein hydrolysates | |
AU539195B2 (en) | Determination of low density lipoproteins | |
PH23978A (en) | Process for the preparation of glycerophosphocholine and glycerophosphoethanolamine derivatives | |
ATE2090T1 (de) | Verfahren zur herstellung eines plasminogenaktivators, so erhaltener aktivator und ihn enthaltendes arzneimittel. | |
GB2118948B (en) | Method for separation of hemoglobin a1c | |
DK217981A (da) | Fremgangsmaade til fremstilling af blodplasmafraktioner | |
JPS5615215A (en) | Preparation of human immunoglobulin for intravenous injection with immobilized pepsin gel | |
DE3362547D1 (en) | Process for the biological preparation of glutathione | |
GB2131028B (en) | Immobilized pepsin for removing blood immune complex and method for removing blood immune complex using immobilized pepsin | |
DE3260844D1 (en) | Process for separating the (r,s) racemate of cysteine | |
AU575151B2 (en) | The use of gonadoliberin and gonadoliberin agonists for the treatment of climacteric complaints | |
DE3064490D1 (en) | Process for the preparation of the third component of the complement as made from human blood plasma | |
AU1023183A (en) | Process for treating anestrus in ewes or beef cattle | |
AU554313B2 (en) | Immobilized pepsin for removing blood immune complex and method for removing blood immune complex using immobilized pepsin | |
EP0070167A3 (en) | Hypertension treatment | |
ES517325A0 (es) | Procedimiento de tratamiento de substancias proteinicas. | |
DD209820A5 (de) | Verfahren zur herstellung von 2,4 substituierten-1,2,3 - 2h-triazol-5-carbonsaeuren | |
FI945325A (fi) | Menetelmä G-CSF:n eristämiseksi ja puhdistamiseksi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC1A | Transfer granted | ||
FD1A | Patent lapsed |
Effective date: 20040601 |